down arrow

Sai Parenteral's

Not Rated
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
  • View on NSE | View on BSE
INR
506.40
-2.9 (-0.57%)
BSENSE

Sep 24, 03:31 PM

BSE+NSE Vol: 87.58 k

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sai Parenteral's Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
No of Months
12
12
12
12
Profit Before Tax
11.00
19.00
12.00
7.00
Adjustment
30.00
20.00
20.00
11.00
Changes In working Capital
55.00
-6.00
-63.00
-28.00
Cash Flow after changes in Working Capital
97.00
33.00
-29.00
-10.00
Cash Flow from Operating Activities
93.00
33.00
-29.00
-12.00
Cash Flow from Investing Activities
-273.00
0.00
-46.00
-19.00
Cash Flow from Financing Activities
595.00
-35.00
78.00
23.00
Net Cash Inflow / Outflow
414.00
-2.00
2.00
-7.00
Opening Cash & Cash Equivalents
2.00
4.00
1.00
9.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
416.00
2.00
4.00
1.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sai Parenteral's
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
11.93
86.98
-75.00
-86.28%
Adjustment
30.54
36.74
-6.00
-16.88%
Changes In working Capital
55.51
-3.63
58.00
1629.20%
Cash Flow after changes in Working Capital
97.98
120.09
-23.00
-18.41%
Cash Flow from Operating Activities
93.05
104.93
-11.00
-11.32%
Cash Flow from Investing Activities
-273.82
-91.79
-182.00
-198.31%
Cash Flow from Financing Activities
595.65
-13.03
608.00
4671.37%
Net Cash Inflow / Outflow
414.88
0.11
414.00
377063.64%
Opening Cash & Cash Equivalents
2.09
0.42
2.00
397.62%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
416.97
0.54
416.00
77116.67%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 180.69% vs 211.39% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
93.05
33.15
180.69%

Footer loading